Skip to main content
SpringerLink
Log in

Antiphospholipid Syndrome — Experimental Models: Insight into Etiology, Pathogenesis, and Treatments

  • Chapter
Hughes Syndrome

  • 747 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hughes GRV, Harris EN, Gharavi AE. The anti-cardiolipin syndrome. J Rheumatol 1986;13:486–489.

    PubMed  CAS  Google Scholar 

  2. Asherson RA, Cervera R, Piette JC, Shoenfeld Y. Milestones in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, eds. The antiphospholipid syndrome II — autoimmune thrombosis. Amsterdam: Elsevier; 2002.

    Google Scholar 

  3. Galli M, Comfurious P, Massen C, et al. Anti-cardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544–1547.

    Article  PubMed  CAS  Google Scholar 

  4. Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003;12:497–498.

    Article  PubMed  CAS  Google Scholar 

  5. Cervera R, Piette JC, Font J, et al. Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019–1027.

    Article  PubMed  Google Scholar 

  6. Asherson RA, Cervera R. Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol 2003;25:61–78.

    Article  PubMed  Google Scholar 

  7. Gharavi AE, Mellors RC, Elkon KB. IgG anti-cardiolipin antibodies in murine lupus. Clin Exp Immunol 1989;78:233–238.

    PubMed  CAS  Google Scholar 

  8. Aron AL, Cuellar ML, Brey RL, et al. Early onset of autoimmunity in MRL/++ mice following immunization with beta 2 glycoprotein I. Clin Exp Immunol 1995;101:78–81.

    Article  PubMed  CAS  Google Scholar 

  9. Hashimoto Y, Kawamura M, Ichikawa K, et al. Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol 1992;149:1063–1068.

    PubMed  CAS  Google Scholar 

  10. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991;88:3069–3073.

    Article  PubMed  CAS  Google Scholar 

  11. Piona A, La Rosa L, Tincani A, et al. Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin Abs in pregnant naive BALB/c mice. Scand J Immunol 1995;41:427–432.

    PubMed  CAS  Google Scholar 

  12. Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211–220.

    Article  PubMed  CAS  Google Scholar 

  13. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid Abs cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990;163:210–216.

    PubMed  CAS  Google Scholar 

  14. Shoenfeld Y, Nahum A, Korczyn AD, et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003;12:436–442.

    Article  PubMed  CAS  Google Scholar 

  15. Jerne NK. Towards a network theory of the immune system. Ann Immunol 1974;125c:373–389.

    CAS  Google Scholar 

  16. Jerne NK, Roland J, Cazenave PA. Recurrent idiotopes and internal images. EMBO J 1982;1:243–247.

    PubMed  CAS  Google Scholar 

  17. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992;89:1558–1563.

    PubMed  CAS  Google Scholar 

  18. Blank M, Krause I, Ben-Bassat M, Shoenfeld Y. Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmun 1992;5:495–509.

    Article  PubMed  CAS  Google Scholar 

  19. Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994;8:1296–1301.

    PubMed  CAS  Google Scholar 

  20. Shoenfeld Y. The idiotypic network in autoimmunity: Abs that bind Abs that bind Abs. Nat Med 2004;10:17–18.

    Article  PubMed  CAS  Google Scholar 

  21. Blank M, Faden D, Tincani A, et al. Immunization with cardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994;7:441–455.

    Article  PubMed  CAS  Google Scholar 

  22. Robertson SA, Roberts CT, van Beijering E, et al. Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Mol Hum Reprod 2004;10:409–416.

    Article  PubMed  CAS  Google Scholar 

  23. Pierangeli SS, Espinola RG, Liu X, Harris NE. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and Pselectin. Circ Res 2001;88:245–250.

    PubMed  CAS  Google Scholar 

  24. Espinola RG, Liu X, Colden-Stanfield M, Hall J, Harris EN, Pierangeli SS. E-Selectin mediates pathogenic effects of antiphospholipid antibodies. Thromb Haemost 2003;1:843–848.

    Article  CAS  Google Scholar 

  25. George J, Shoenfeld Y, Harats D. The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. J Autoimmun 1999;13:57–60.

    Article  PubMed  CAS  Google Scholar 

  26. George J, Harats D, Gilburd B, et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice Circulation 2000;102:1822–1827.

    PubMed  CAS  Google Scholar 

  27. Levy Y, Ziporen L, Gilburd B, et al. Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Hum Antibodies Hybridomas 1996;7:91–96.

    PubMed  CAS  Google Scholar 

  28. George J, Blank M, Levy Y, et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998;97:900–906.

    PubMed  CAS  Google Scholar 

  29. Blank M, George J, Barak V, Tincani A, Koike T, Shoenfeld Y. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome. J Immunol 1998;161:5303–5312.

    PubMed  CAS  Google Scholar 

  30. Miyakis S, Robertson SA, Krilis SA. Beta-2 glycoprotein I and its role in antiphospholipid syndromelessons from knockout mice. Clin Immunol 2004;112:136–143.

    Article  PubMed  CAS  Google Scholar 

  31. Blank M, Waisman A, Mozes E, Shoenfeld Y. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome. Int Immunol 1999;11:1917–1926.

    Article  PubMed  CAS  Google Scholar 

  32. Salmon JE, Girardi G, Holers VM. Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 2003;12:535–538.

    Article  PubMed  CAS  Google Scholar 

  33. Gharavi AE, Vega-Ostertag M, Espinola RG, et al. Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies. Lupus 2004;13:17–23.

    Article  PubMed  CAS  Google Scholar 

  34. Ikematsu W, Luan FL, La Rosa L, et al. Human anticardiolipin monoclonal autoAbs cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum 1998;41:1026–1039.

    Article  PubMed  CAS  Google Scholar 

  35. Morrish DW, Dakour J, Li H. Life and death in the placenta: new peptides and genes regulating human syncytiotrophoblast and extravillous cytotrophoblast lineage formation and renewal. Curr Protein Pept Sci 2001;2:245–259.

    Article  PubMed  CAS  Google Scholar 

  36. Blank M, Tincani A, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with purified IgG anti-phosphatidylserine antibodies. J Rheumatol 1994;21:100–104.

    PubMed  CAS  Google Scholar 

  37. Yodfat O, Blank M, Krause I, Shoenfeld Y. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Clin Immunol Immunopathol 1996;78:14–20.

    Article  PubMed  CAS  Google Scholar 

  38. Levy R, DM Nelson. To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 2000;21:1–13.

    Article  PubMed  CAS  Google Scholar 

  39. Shurtz-Swirsky R, Inbar O, Blank M, et al. In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Am J Reprod Immunol 1993;29:206–210.

    Google Scholar 

  40. Sugimura M, Kobayashi T, Shu F, Kanayama N, Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta 1999;20:555–560.

    Article  PubMed  CAS  Google Scholar 

  41. Vogt E, Ng AK, Rote NS. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 1997;177:964–972.

    Article  PubMed  CAS  Google Scholar 

  42. Matalon ST, Shoenfeld Y, Blank M, Yacobi S, von Landenberg P, Ornoy A. Antiphosphatidylserine antibodies affect rat yolk sacs in culture: a mechanism for fetal loss in antiphospholipid syndrome. Am J Reprod Immunol 2004;51:144–151.

    Article  PubMed  Google Scholar 

  43. Di Simone N, Meroni PL, de Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta 2 glycoprotein I. Arthritis Rheum 2000;43:140–150.

    Article  PubMed  Google Scholar 

  44. McIntyre JA. Antiphospholipid antibodies in implantation failures. Am J Reprod Immunol 2003;49:221–229.

    Article  PubMed  CAS  Google Scholar 

  45. Rand JH, Wu XX, Guller S, et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with aPL Abs and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566–1572.

    PubMed  CAS  Google Scholar 

  46. Matsubayashi H, Arai T, Izumi S, Sugi T, McIntyre JA, Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failure. Fertil Steril 2001;76:694–699.

    Article  PubMed  CAS  Google Scholar 

  47. Wang X, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999;180:1008–1016.

    Article  PubMed  CAS  Google Scholar 

  48. Lieby P, Poindron V, Roussi S, et al. Pathogenic antiphospholipid antibody: an antigen selected needle in a haystack. Blood 2004;104:1711–1715.

    Article  PubMed  CAS  Google Scholar 

  49. Blank M, Krause I, Lanir N, Shoenfeld Y. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum 1995;38:115–122.

    PubMed  CAS  Google Scholar 

  50. Blank M, Krause I, Shoenfeld Y. The contribution of experimental models to our understanding of etiology, pathogenesis and novel therapies in the antiphospholipid syndrome. In: Khamashta MA, ed. Hughes syndrome — antiphospholipid syndrome. London: Springer; 2000:379–388.

    Google Scholar 

  51. Krause I, Blank M, Sherer Y, Gilburd B, Kvapil F, Shoenfeld Y. Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins. Eur J Immunol 2002;32:3414–3424.

    PubMed  CAS  Google Scholar 

  52. Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci U S A 1999;96:5164–5168.

    Article  PubMed  CAS  Google Scholar 

  53. Jones DS, Coutts SM, Gamino CA, et al. Multivalent thioether-peptide conjugates: B cell tolerance of an anti-peptide immune response. Bioconjug Chem 1999;10:480–488.

    Article  PubMed  CAS  Google Scholar 

  54. Blank M, Krause I, Wildbaum G, Karin N, Shoenfeld Y. TNFalpha DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome. Lupus 2003;12:546–549.

    Article  PubMed  CAS  Google Scholar 

  55. Reifen R, Amital H, Blank M, et al. Linseed oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome. J Autoimmun 2000;15:381–385.

    Article  PubMed  CAS  Google Scholar 

  56. Pierangeli SS, Harris EN. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus 1994;3:247–251.

    PubMed  CAS  Google Scholar 

  57. Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995;74:1361–1367.

    PubMed  CAS  Google Scholar 

  58. Pierangeli SS, EN Harris. In vivo models of thrombosis for the antiphospholipid syndrome. Lupus 1996;5:451–455.

    PubMed  CAS  Google Scholar 

  59. Gharavi AE, Pierangeli SS, Gharavi AE, et al. Thrombogenic properties of antiphospholipid antibodies do not depend on their binding to beta2 glycoprotein 1 (beta2GP1) alone. Lupus 1998;7:341–346.

    Article  PubMed  CAS  Google Scholar 

  60. Edwards MH, Pierangeli SS, Liu X, Barker JH, Anderson G, Harris EN. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 1997;96:4380–4384.

    PubMed  CAS  Google Scholar 

  61. Pierangeli SS, Espinola R, Liu X, Harris EN, Salmon JE. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum 2001;44:876–883.

    Article  PubMed  CAS  Google Scholar 

  62. Pierangeli SS, Blank M, Liu X, et al. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo. J Autoimmun 2004;22:217–225.

    Article  PubMed  CAS  Google Scholar 

  63. Haj Yahja S, Sherer Y, Blank M, Kaetsu H, Smolinsky A, Shoenfeld Y. Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model. Lupus 2003;12:364–369.

    Article  PubMed  CAS  Google Scholar 

  64. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1984;179:457–462.

    Article  Google Scholar 

  65. Horkko S, Miller E, Branch DW, Palinski W, Witztum JL. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins), Proc Nat Acad Sci U S A 1997;94:10356–10361.

    Article  CAS  Google Scholar 

  66. Levine JS, Koh JS, Subang R, Rauch J. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome. Exp Mol Pathol 1999;66:82–98.

    Article  PubMed  CAS  Google Scholar 

  67. Levine JS, Subang R, Koh JS, Rauch J. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes. J Autoimmun 1998;11:413–424.

    Article  PubMed  CAS  Google Scholar 

  68. Tincani A, Gilburd B, Abu-Shakra M, et al. Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule. Arthritis Rheum 2002;46:1399–1404.

    Article  PubMed  CAS  Google Scholar 

  69. Blank M, Y Shoenfeld. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 2004;112:190–199.

    Article  PubMed  CAS  Google Scholar 

  70. Blank M, Asherson RA, Cervera R, Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol 2004;24:12–23.

    Article  PubMed  CAS  Google Scholar 

  71. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to β2glycoprotein I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002;106:797–804.

    Article  CAS  Google Scholar 

  72. Shoenfeld Y. Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unraveled. Trends Immunol 2003;24:2–4.

    Article  PubMed  CAS  Google Scholar 

  73. Gharavi AE, Pierangeli SS, Colden M, Liu X, Espinola RG, Harris EN. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol 1999;163:2922–2927.

    PubMed  CAS  Google Scholar 

  74. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden-Stanfield M, Harris EN. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002;46:545–552.

    Article  PubMed  CAS  Google Scholar 

  75. Smith HR, Hansen CL, Rose R, Canoso RT. Autoimmune MRL-lpr/lpr mice are an animal model for the secondary antiphospholipid syndrome. J Rheumatol 1990;17:911–915.

    PubMed  CAS  Google Scholar 

  76. Hess DC. Models for central nervous system complications of antiphospholipid syndrome. Lupus 1994;3:253–257.

    PubMed  CAS  Google Scholar 

  77. Katzav A, Kloog Y, Korczyn AD, et al. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin Exp Immunol 2001;126:570–577.

    Article  PubMed  CAS  Google Scholar 

  78. Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 1997;100:613–619.

    Article  PubMed  CAS  Google Scholar 

  79. Ziporen L, Polak Charcon S, Korczyn D, et al. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin Dev Immunol 2004;11:67–75.

    Article  PubMed  Google Scholar 

  80. Katzav A, Pick CG, Korczyn AD, et al. Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus 2001;7:494–499.

    Google Scholar 

  81. Shoenfeld Y, Nahum A, Korczyn AD, et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003;12:436–442.

    Article  PubMed  CAS  Google Scholar 

  82. Ziporen L, Goldberg I, Arad M, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 1996;5:196–205.

    PubMed  CAS  Google Scholar 

  83. Libman E, Sacks BA. Hitherto undescribed from of valvular and mural endocarditis. Arch Intern Med 1924;33:701–737.

    Google Scholar 

  84. Asherson RA, Hughes GRV. The expanding spectrum of Libman Sacks endocarditis; the role of antiphospholipid antibodies. Clin Exp Rheumatol 1989;7:225–228.

    PubMed  CAS  Google Scholar 

  85. Blank M, Shani A, Goldberg I, et al. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. Thromb Res 2004. In press.

    Google Scholar 

  86. Vianna JL, Trotter S, Khamashta MA, Chikte S, Olsen E, Hughes GR. The heart and antiphospholipid antibodies in MRL-lpr/lpr mice. Lupus 1992;1:1357–1361.

    Google Scholar 

  87. Nzerue CM, Hewan-Lowe K, Pierangeli SS, Harris EN. “Black swan in the kidney”: renal involvement in the antiphospholipid antibody syndrome. Kidney Int 2002;62:733–744.

    Article  PubMed  CAS  Google Scholar 

  88. George J, Afek A, Gilburd B, et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 1998;98:1108–1115.

    PubMed  CAS  Google Scholar 

  89. George J, Afek A, Gilburd B, et al. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997;6:723–729.

    PubMed  CAS  Google Scholar 

  90. George J, Yacov N, Breitbart E, et al. Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. Cardiovasc Res 2004;62:603–609.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel

    Miri Blank PhD

  2. Department of Internal Medicine F, Rabin Medical Center, Petah-Tiqva, Israel

    Ilan Krause MD

  3. Department of Internal Medicine B and Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Israel

    Yehuda Shoenfeld MD, FRCP

  4. Incumbent of the Laura Schwarz-Kipp Chair for Autoimmunity, Tel-Aviv University, Israel

    Yehuda Shoenfeld MD, FRCP

Authors
  1. Miri Blank PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilan Krause MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yehuda Shoenfeld MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Blank, M., Krause, I., Shoenfeld, Y. (2006). Antiphospholipid Syndrome — Experimental Models: Insight into Etiology, Pathogenesis, and Treatments. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_30

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_30

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation